A
Andrée Rothermel
Researcher at University of Mainz
Publications - 3
Citations - 1636
Andrée Rothermel is an academic researcher from University of Mainz. The author has contributed to research in topics: Cancer & Peptide microarray. The author has an hindex of 3, co-authored 3 publications receiving 1195 citations.
Papers
More filters
Journal ArticleDOI
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin,Evelyna Derhovanessian,Matthias Miller,Björn-Philipp Kloke,Petra Simon,Martin Löwer,Valesca Bukur,Arbel D. Tadmor,Ulrich Luxemburger,Barbara Schrörs,Tana Omokoko,Mathias Vormehr,Christian Albrecht,Anna Paruzynski,Andreas Kuhn,Janina Buck,Sandra Heesch,Katharina H Schreeb,Felicitas Müller,Inga Ortseifer,Isabel Vogler,Eva Godehardt,Sebastian Attig,Richard Rae,Andrea Breitkreuz,Claudia Tolliver,Martin Suchan,Goran Martic,Alexander Hohberger,Patrick Sorn,Jan Diekmann,Janko Ciesla,Olga Waksmann,Alexandra-Kemmer Brück,Meike Witt,Martina Zillgen,Andrée Rothermel,Barbara Kasemann,David Langer,Stefanie Bolte,Mustafa Diken,Sebastian Kreiter,Romina Nemecek,Christoffer Gebhardt,Christoffer Gebhardt,Stephan Grabbe,Christoph Höller,Jochen Utikal,Jochen Utikal,Christoph Huber,Carmen Loquai,Özlem Türeci +51 more
TL;DR: The first-in-human application of individualized mutanome vaccines in melanoma is reported, demonstrating that individual mutations can be exploited and opening a path to personalized immunotherapy for patients with cancer.
Journal ArticleDOI
rapmad: Robust analysis of peptide microarray data
Bernhard Y. Renard,Martin Löwer,Yvonne Kühne,Ulf Reimer,Andrée Rothermel,Özlem Türeci,John C. Castle,Ugur Sahin +7 more
TL;DR: rapmad allows the robust and sensitive, automated analysis of high-throughput peptide array data and shows substantially improved sensitivity for low intensity settings without sacrificing specificity, contributing to increasing the effectiveness of high throughput screening experiments.
Patent
Methods and kits for the diagnosis of cancer
TL;DR: The present invention relates to methods and kits for the diagnosis, prognosis and/or monitoring of cancer in a patient as mentioned in this paper, which relates to isolated peptides, panels of isolated peptide and diagnostic devices.